Patients with central sleep apnea can finally go to sleep with relief now. The US FDA has approved a new implantable device to treat moderate to severe central sleep apnea. Implantable device regulates breathing by stimulating a nerve responsible for sending signals to the diaphragm to stimulate breathing. Central Sleep apnea is a potentially serious sleep disorder in which breathing repeatedly stops and starts.
Central sleep apnea leads to poor sleep quality and serious health issues including high blood pressure, heart attack, heart failure, stroke, obesity, and diabetes. Common treatment options for moderate to severe sleep apnea include medication, positive airway pressure devices (CPAP machine), or surgery. New Implantable Device This new implantable device consists of a battery pack surgically placed under the skin in the upper chest area and small, thin wires are inserted into…
